Neith Corporation

TWO:6236 Taiwan Biotechnology
Market Cap
$27.19 Million
NT$899.73 Million TWD
Market Cap Rank
#32733 Global
#1883 in Taiwan
Share Price
NT$21.60
Change (1 day)
+0.00%
52-Week Range
NT$19.60 - NT$31.50
All Time High
NT$31.50
About

Neith Corporation engages in the biotechnology, medical cosmetics, and preventive medicine businesses. The company offers nutritional products, including L-One, a liquid formula for maintaining eye health; EPlus, a multiple enzyme supplement; and other nutritional products under the King One name. It also provides genetic testing services. In addition, the company offers energy and dual-purpose m… Read more

Neith Corporation (6236) - Total Liabilities

Latest total liabilities as of September 2025: NT$13.40 Million TWD

Based on the latest financial reports, Neith Corporation (6236) has total liabilities worth NT$13.40 Million TWD as of September 2025.

Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Neith Corporation - Total Liabilities Trend (2021–2024)

This chart illustrates how Neith Corporation's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.

Neith Corporation Competitors by Total Liabilities

The table below lists competitors of Neith Corporation ranked by their total liabilities.

Company Country Total Liabilities
Buyuk Sefler Gida Turizm
IS:BIGCH
Turkey TL1.13 Billion
11880 Solutions AG
XETRA:TGT
Germany €20.68 Million
UJOGF
OTCQB:UJOGF
USA $2.16 Million
Polaris Investama Tbk
JK:PLAS
Indonesia Rp31.27 Billion
Metalsgrove Mining Ltd
AU:MGA
Australia AU$123.69K

Liability Composition Analysis (2021–2024)

This chart breaks down Neith Corporation's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 17.06 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.09 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.08 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Neith Corporation's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Neith Corporation (2021–2024)

The table below shows the annual total liabilities of Neith Corporation from 2021 to 2024.

Year Total Liabilities Change
2024-12-31 NT$16.57 Million -4.97%
2023-12-31 NT$17.43 Million -14.42%
2022-12-31 NT$20.37 Million +300.85%
2021-12-31 NT$5.08 Million --